Table III.
Overall survival rate of chemotherapy-sensitive (2 complete response and 7 partial response) and chemotherapy-resistant (12 stable disease and 0 progressive disease) patients with cervical cancer following surgery.
| Factor | Chemotherapy-sensitive, n/total n (%) | Chemotherapy-resistant, n/total n (%) | Total mortality, n/total n (%) |
|---|---|---|---|
| Mortality based on SCCA level pre-chemotherapy | |||
| + | 2/7 (28.6) | 4/10 (40.0) | 6/17 (35.3) |
| − | 0/2 (0.0) | 0/2 (0.0) | 0/4 (0.0) |
| Mortality based on SCCA level post-chemotherapy | |||
| + | 2/3 (66.7) | 4/8 (50.0) | 6/11 (54.5) |
| − | 0/6 (0.0) | 0/4 (0.0) | 0/10 (0.0) |
| Total mortality | 2/9 (22.2) | 4/12 (33.3) | 6/21 (28.6) |
SCCA, squamous cell carcinoma antigen; CR, complete response; PR, partial response; PD, progressive disease; SD, stable disease; +, SCCA-positive expression; -, SCCA-negative expression.